FDA will not seek Supreme Court review in off-label promotion case

NEWS IN BRIEF — Posted Feb. 11, 2013

Print  |   Email  |   Respond  |   Reprints  |   Like Facebook  |   Share Twitter  |   Tweet Linkedin

The Food and Drug Administration will not fight an appeals court decision enabling pharmaceutical representatives to promote appropriate off-label uses for their medications without penalty.

The 2nd U.S. Circuit Court of Appeals in December 2012 ruled that blocking drug companies from promoting truthful statements about off-label drug uses violates the First Amendment. The decision exonerated former Orphan Medical Inc. drug representative Alfred Caronia, who was convicted of illegally marketing narcolepsy drug Xyrem (sodium oxybate) for uses that were not described in the drug’s labeling. Under the federal Food, Drug and Cosmetic Act, drugmakers are prohibited from marketing drugs for unapproved uses.

In a statement issued in January, the FDA said it had determined not to seek further review of the 2nd Circuit’s decision. The FDA does not believe that the Caronia decision will significantly affect the agency’s enforcement of the federal law’s drug misbranding provisions, the agency said. It added that the court’s decision does not strike down any provisions of the law or call into question the validity of the law’s drug approval framework.

Back to top



Read story

Confronting bias against obese patients

Medical educators are starting to raise awareness about how weight-related stigma can impair patient-physician communication and the treatment of obesity. Read story

Read story


American Medical News is ceasing publication after 55 years of serving physicians by keeping them informed of their rapidly changing profession. Read story

Read story

Policing medical practice employees after work

Doctors can try to regulate staff actions outside the office, but they must watch what they try to stamp out and how they do it. Read story

Read story

Diabetes prevention: Set on a course for lifestyle change

The YMCA's evidence-based program is helping prediabetic patients eat right, get active and lose weight. Read story

Read story

Medicaid's muddled preventive care picture

The health system reform law promises no-cost coverage of a lengthy list of screenings and other prevention services, but some beneficiaries still might miss out. Read story

Read story

How to get tax breaks for your medical practice

Federal, state and local governments offer doctors incentives because practices are recognized as economic engines. But physicians must know how and where to find them. Read story

Read story

Advance pay ACOs: A down payment on Medicare's future

Accountable care organizations that pay doctors up-front bring practice improvements, but it's unclear yet if program actuaries will see a return on investment. Read story

Read story

Physician liability: Your team, your legal risk

When health care team members drop the ball, it's often doctors who end up in court. How can physicians improve such care and avoid risks? Read story

  • Stay informed
  • Twitter
  • Facebook
  • RSS
  • LinkedIn